John McGrath, EVP & Chief Financial Officer at Atara Biotherapeutics, Inc. (ATRA), sold 14,000 shares at $20.27 ($289K) on 2017-03-22, disclosed to the SEC on 2017-03-23.
Open-market sale of $289k ATRA by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.27 | 7,500 | $152K | 52.6% |
| 2 | $21.08 | 6,500 | $137K | 47.4% |
| Total | $20.65 avg | 14,000 | $289K | 100% |
| Filing → |
| ATRA | SELL | 2018-01-12 | $901K | — | Filing → |
| ATRA | SELL | 2018-01-02 | $640K | — | Filing → |
| ATRA | SELL | 2017-08-17 | $60K | — | Filing → |